In a large real world study, tirzepatide was associated with a lower incidence of major cardiovascular outcomes vs semaglutide: Composite CV outcome: 1.90% vs 2.18% (HR 0.86, p=0.01) New onset heart 5 amino 1mq capsules How Big Are the Needles for Semaglutide Injections? Drug Direct Lower Costs for Prescription Drugs liraglutide 0.6 mg 0.1 mL (18 mg 3 mL) subcutaneous pen injector Kaiser Permanente